Plain-English translation of NCT03554902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial follows patients who undergo endoscopic gastric tubulization, a minimally invasive procedure that uses a special stitching device called Overstitch to make the stomach smaller. Unlike traditional weight-loss surgery, this procedure is performed through the mouth without any surgical cuts, making it safer with fewer complications. The trial will track how much weight patients lose and how their overall health improves over two years.
Traditional weight-loss surgery works well but carries real risks of serious complications. This trial exists to prove that this newer, less invasive endoscopic approach can achieve similar weight loss and health benefits while being much safer and easier to reverse if needed.
You likely qualify if…
You likely don't qualify if…
You would receive the endoscopic gastric tubulization procedure at the hospital and then return for follow-up visits before the procedure and at regular intervals over the next two years. During these visits, doctors will measure your weight, assess your quality of life, check whether your obesity-related health conditions have improved, and evaluate how well the procedure is working for you. All of this data will be collected as part of your standard medical care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France
Enrollment target
~300 participants
Started
June 2018
Primary completion
June 2028
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Silvana Perretta, MD, PhD
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.